Glecaprevir-Pibrentasvir Effective in Patients With HCV, CKD Glecaprevir-Pibrentasvir Effective in Patients With HCV, CKD
Glecaprevir-pibrentasvir produced high sustained virologic response rates regardless of the underlying HCV genotype in patients with severe chronic kidney disease and HCV infection, a study found.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
More News: Chronic Kidney Disease | Gastroenterology | Health | Study | Urology & Nephrology | Virology